 Anthony Saviola
Concepts (295)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crotalid Venoms | 14 | 2025 | 31 | 4.570 |
Why?
| | Crotalus | 14 | 2025 | 26 | 3.890 |
Why?
| | Snake Venoms | 12 | 2025 | 25 | 3.170 |
Why?
| | Proteomics | 21 | 2025 | 1111 | 2.920 |
Why?
| | Proteome | 10 | 2025 | 472 | 1.450 |
Why?
| | Disintegrins | 2 | 2016 | 5 | 0.990 |
Why?
| | Fibrinolytic Agents | 2 | 2025 | 270 | 0.920 |
Why?
| | Thrombosis | 3 | 2025 | 371 | 0.880 |
Why?
| | Blood Coagulation | 2 | 2025 | 255 | 0.850 |
Why?
| | Colubridae | 3 | 2021 | 10 | 0.850 |
Why?
| | Fibrinolysis | 1 | 2025 | 146 | 0.830 |
Why?
| | Peptides | 4 | 2025 | 985 | 0.790 |
Why?
| | Antivenins | 4 | 2025 | 36 | 0.760 |
Why?
| | Extracellular Matrix | 9 | 2025 | 528 | 0.760 |
Why?
| | Head and Neck Neoplasms | 5 | 2024 | 606 | 0.730 |
Why?
| | Animals | 48 | 2025 | 36940 | 0.680 |
Why?
| | Neglected Diseases | 1 | 2020 | 4 | 0.660 |
Why?
| | Metalloproteases | 4 | 2024 | 43 | 0.560 |
Why?
| | Cell Adhesion | 2 | 2016 | 466 | 0.550 |
Why?
| | L-Amino Acid Oxidase | 4 | 2019 | 4 | 0.550 |
Why?
| | Mass Spectrometry | 5 | 2023 | 739 | 0.520 |
Why?
| | Predatory Behavior | 2 | 2016 | 50 | 0.520 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 59 | 0.460 |
Why?
| | Elapid Venoms | 2 | 2025 | 18 | 0.460 |
Why?
| | Extracellular Matrix Proteins | 3 | 2025 | 153 | 0.450 |
Why?
| | Collagen Type I | 2 | 2025 | 136 | 0.420 |
Why?
| | Biological Evolution | 2 | 2017 | 474 | 0.410 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2025 | 289 | 0.390 |
Why?
| | Mice | 19 | 2025 | 17787 | 0.360 |
Why?
| | Vitronectin | 2 | 2025 | 9 | 0.360 |
Why?
| | Fibronectins | 2 | 2025 | 133 | 0.330 |
Why?
| | Phospholipases A2 | 5 | 2025 | 80 | 0.320 |
Why?
| | Melanoma | 1 | 2016 | 760 | 0.300 |
Why?
| | Tumor Microenvironment | 4 | 2025 | 674 | 0.290 |
Why?
| | Hydrogels | 3 | 2025 | 678 | 0.290 |
Why?
| | Pancreatic Neoplasms | 3 | 2025 | 938 | 0.280 |
Why?
| | Cell Line, Tumor | 7 | 2025 | 3412 | 0.270 |
Why?
| | Viper Venoms | 2 | 2018 | 9 | 0.270 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4295 | 0.270 |
Why?
| | Fibrosis | 3 | 2024 | 552 | 0.270 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 2019 | 345 | 0.270 |
Why?
| | Transcriptome | 2 | 2025 | 971 | 0.260 |
Why?
| | Proteolysis | 2 | 2025 | 177 | 0.260 |
Why?
| | Toxins, Biological | 2 | 2023 | 12 | 0.250 |
Why?
| | Female Urogenital Diseases | 1 | 2025 | 7 | 0.240 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2025 | 14 | 0.240 |
Why?
| | Collagen | 2 | 2025 | 452 | 0.240 |
Why?
| | Murinae | 1 | 2025 | 6 | 0.240 |
Why?
| | Factor XIII | 1 | 2025 | 11 | 0.240 |
Why?
| | Blastocyst | 1 | 2025 | 48 | 0.240 |
Why?
| | Coral Snakes | 1 | 2025 | 3 | 0.240 |
Why?
| | Mexico | 3 | 2025 | 225 | 0.230 |
Why?
| | Protein Phosphatase 1 | 1 | 2025 | 33 | 0.230 |
Why?
| | Biomimetics | 1 | 2025 | 44 | 0.230 |
Why?
| | Interleukin-2 | 2 | 2023 | 455 | 0.230 |
Why?
| | Transcription Termination, Genetic | 1 | 2025 | 19 | 0.230 |
Why?
| | Dystrophin-Associated Proteins | 1 | 2024 | 6 | 0.230 |
Why?
| | Mammary Glands, Human | 1 | 2025 | 64 | 0.230 |
Why?
| | Dystrophin | 1 | 2024 | 35 | 0.230 |
Why?
| | Receptor, EphB4 | 1 | 2024 | 34 | 0.220 |
Why?
| | Ephrin-B2 | 1 | 2024 | 47 | 0.220 |
Why?
| | Prodrugs | 1 | 2025 | 52 | 0.220 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 1 | 2024 | 13 | 0.220 |
Why?
| | Biomimetic Materials | 1 | 2025 | 72 | 0.220 |
Why?
| | Fibrin | 1 | 2025 | 81 | 0.220 |
Why?
| | Humans | 34 | 2025 | 137585 | 0.220 |
Why?
| | Keto Acids | 1 | 2024 | 13 | 0.220 |
Why?
| | Embryonic Development | 1 | 2025 | 119 | 0.220 |
Why?
| | Printing, Three-Dimensional | 1 | 2025 | 95 | 0.220 |
Why?
| | Indoles | 2 | 2025 | 412 | 0.220 |
Why?
| | PPAR alpha | 1 | 2024 | 58 | 0.220 |
Why?
| | Oleic Acid | 1 | 2024 | 40 | 0.220 |
Why?
| | Snake Bites | 1 | 2024 | 29 | 0.220 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2024 | 38 | 0.220 |
Why?
| | Lactation | 1 | 2025 | 181 | 0.210 |
Why?
| | Hydroxamic Acids | 1 | 2024 | 89 | 0.210 |
Why?
| | Interleukin-7 | 1 | 2024 | 61 | 0.210 |
Why?
| | Herpesvirus 3, Human | 2 | 2024 | 332 | 0.210 |
Why?
| | Acetates | 1 | 2024 | 99 | 0.210 |
Why?
| | Birth Injuries | 1 | 2023 | 9 | 0.210 |
Why?
| | Lipid Droplets | 1 | 2023 | 23 | 0.210 |
Why?
| | Milk, Human | 1 | 2025 | 158 | 0.210 |
Why?
| | Lethal Dose 50 | 2 | 2025 | 15 | 0.210 |
Why?
| | High-Throughput Screening Assays | 1 | 2025 | 158 | 0.210 |
Why?
| | Vagina | 1 | 2025 | 187 | 0.210 |
Why?
| | Phenotype | 6 | 2023 | 3196 | 0.200 |
Why?
| | Regeneration | 1 | 2025 | 197 | 0.200 |
Why?
| | Necrosis | 1 | 2024 | 246 | 0.200 |
Why?
| | RNA Precursors | 1 | 2024 | 154 | 0.200 |
Why?
| | Protein Isoforms | 1 | 2024 | 404 | 0.200 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 169 | 0.200 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2025 | 159 | 0.200 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 51 | 0.200 |
Why?
| | Osteoarthritis | 1 | 2025 | 185 | 0.200 |
Why?
| | Tissue Scaffolds | 1 | 2025 | 211 | 0.200 |
Why?
| | Herpes Zoster | 2 | 2024 | 316 | 0.200 |
Why?
| | RNA Splicing | 1 | 2024 | 269 | 0.200 |
Why?
| | Vascular Remodeling | 1 | 2024 | 193 | 0.200 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2526 | 0.200 |
Why?
| | Peptide Hydrolases | 1 | 2023 | 111 | 0.200 |
Why?
| | Wound Healing | 1 | 2025 | 331 | 0.190 |
Why?
| | Menopause | 1 | 2025 | 320 | 0.190 |
Why?
| | Gene Expression | 2 | 2025 | 1502 | 0.190 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 146 | 0.190 |
Why?
| | Osteoarthritis, Knee | 1 | 2025 | 254 | 0.190 |
Why?
| | Ventricular Remodeling | 1 | 2024 | 266 | 0.190 |
Why?
| | RNA Polymerase II | 1 | 2025 | 324 | 0.180 |
Why?
| | Myocardium | 2 | 2024 | 1002 | 0.180 |
Why?
| | Progesterone | 1 | 2023 | 254 | 0.180 |
Why?
| | MCF-7 Cells | 3 | 2018 | 124 | 0.180 |
Why?
| | Microglia | 1 | 2024 | 251 | 0.180 |
Why?
| | RNA-Binding Proteins | 1 | 2025 | 422 | 0.180 |
Why?
| | Virulence Factors | 1 | 2022 | 167 | 0.170 |
Why?
| | Cattle | 4 | 2025 | 984 | 0.170 |
Why?
| | Reactive Oxygen Species | 3 | 2022 | 622 | 0.160 |
Why?
| | Evolution, Molecular | 1 | 2024 | 493 | 0.160 |
Why?
| | Semen | 1 | 2020 | 18 | 0.160 |
Why?
| | Nuclear Proteins | 1 | 2025 | 712 | 0.160 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 801 | 0.160 |
Why?
| | Drug Discovery | 1 | 2021 | 142 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 1 | 2024 | 557 | 0.160 |
Why?
| | Cardiomyopathies | 1 | 2023 | 350 | 0.160 |
Why?
| | Trimeresurus | 1 | 2019 | 1 | 0.160 |
Why?
| | Serine Proteases | 1 | 2019 | 19 | 0.150 |
Why?
| | Chromatin | 1 | 2023 | 519 | 0.150 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2019 | 46 | 0.150 |
Why?
| | Mice, Knockout | 2 | 2024 | 3015 | 0.150 |
Why?
| | Epithelial Cells | 1 | 2025 | 1096 | 0.150 |
Why?
| | Reptilian Proteins | 1 | 2018 | 3 | 0.150 |
Why?
| | Gene Expression Regulation | 2 | 2025 | 2607 | 0.150 |
Why?
| | Breast Neoplasms | 2 | 2025 | 2253 | 0.150 |
Why?
| | Metabolomics | 1 | 2023 | 678 | 0.140 |
Why?
| | Proteins | 2 | 2023 | 1009 | 0.140 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 144 | 0.140 |
Why?
| | Gryllidae | 1 | 2017 | 1 | 0.140 |
Why?
| | Alzheimer Disease | 1 | 2024 | 560 | 0.140 |
Why?
| | Apoptosis | 2 | 2018 | 2553 | 0.140 |
Why?
| | Mitochondria | 1 | 2024 | 948 | 0.140 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1502 | 0.140 |
Why?
| | Southwestern United States | 1 | 2017 | 91 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2024 | 900 | 0.140 |
Why?
| | Lizards | 1 | 2017 | 35 | 0.140 |
Why?
| | Hypoxia | 1 | 2024 | 1112 | 0.140 |
Why?
| | Myocardial Infarction | 1 | 2024 | 1046 | 0.130 |
Why?
| | Integrin alphaVbeta3 | 1 | 2016 | 18 | 0.130 |
Why?
| | Adenylyl Cyclases | 1 | 2016 | 87 | 0.130 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 433 | 0.130 |
Why?
| | RNA | 1 | 2023 | 921 | 0.130 |
Why?
| | Female | 13 | 2025 | 73304 | 0.120 |
Why?
| | Bacteria | 1 | 2022 | 858 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1774 | 0.120 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 532 | 0.120 |
Why?
| | Neutralization Tests | 2 | 2025 | 75 | 0.120 |
Why?
| | DNA, Complementary | 1 | 2015 | 272 | 0.110 |
Why?
| | Geography | 1 | 2015 | 200 | 0.110 |
Why?
| | Phylogeny | 3 | 2025 | 904 | 0.110 |
Why?
| | Stroke | 1 | 2023 | 1120 | 0.110 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2016 | 327 | 0.110 |
Why?
| | Tumor Suppressor Proteins | 1 | 2016 | 327 | 0.110 |
Why?
| | Neoplasms | 2 | 2021 | 2671 | 0.100 |
Why?
| | Antineoplastic Agents | 2 | 2025 | 2129 | 0.100 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2023 | 81 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2024 | 1910 | 0.100 |
Why?
| | Chromatography, Gel | 1 | 2013 | 127 | 0.100 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2015 | 597 | 0.100 |
Why?
| | Molecular Weight | 1 | 2013 | 335 | 0.100 |
Why?
| | Zinc | 1 | 2015 | 297 | 0.090 |
Why?
| | Cell Movement | 1 | 2016 | 967 | 0.090 |
Why?
| | Swine | 2 | 2025 | 775 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 283 | 0.090 |
Why?
| | Male | 7 | 2025 | 67762 | 0.080 |
Why?
| | Immunotherapy | 2 | 2025 | 641 | 0.080 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 500 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2139 | 0.080 |
Why?
| | Heart Failure | 1 | 2022 | 2236 | 0.070 |
Why?
| | Protein Binding | 2 | 2025 | 2224 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2016 | 2475 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2900 | 0.070 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5757 | 0.070 |
Why?
| | Bacterial Proteins | 2 | 2025 | 879 | 0.070 |
Why?
| | Signal Transduction | 3 | 2025 | 5079 | 0.060 |
Why?
| | Rats | 2 | 2025 | 5647 | 0.060 |
Why?
| | Exocrine Glands | 1 | 2025 | 5 | 0.060 |
Why?
| | Salivary Glands | 1 | 2025 | 33 | 0.060 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2025 | 16 | 0.060 |
Why?
| | Drug Liberation | 1 | 2025 | 35 | 0.060 |
Why?
| | Colorado | 1 | 2015 | 4565 | 0.060 |
Why?
| | Naja | 1 | 2024 | 1 | 0.060 |
Why?
| | Elapidae | 1 | 2024 | 5 | 0.060 |
Why?
| | RNA Splice Sites | 1 | 2024 | 45 | 0.060 |
Why?
| | Embryo, Mammalian | 1 | 2025 | 232 | 0.060 |
Why?
| | Acute-Phase Proteins | 1 | 2024 | 67 | 0.060 |
Why?
| | Serpins | 1 | 2024 | 31 | 0.060 |
Why?
| | Varicella Zoster Virus Infection | 1 | 2024 | 24 | 0.050 |
Why?
| | Fenofibrate | 1 | 2024 | 28 | 0.050 |
Why?
| | Saccharomycetales | 1 | 2024 | 27 | 0.050 |
Why?
| | Drug Repositioning | 1 | 2024 | 35 | 0.050 |
Why?
| | Weight-Bearing | 1 | 2025 | 173 | 0.050 |
Why?
| | Virus Activation | 1 | 2024 | 88 | 0.050 |
Why?
| | Acrylamides | 1 | 2024 | 57 | 0.050 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2024 | 89 | 0.050 |
Why?
| | Estrogen Receptor alpha | 1 | 2025 | 145 | 0.050 |
Why?
| | Corpus Luteum | 1 | 2023 | 20 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 115 | 0.050 |
Why?
| | Species Specificity | 1 | 2025 | 585 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 98 | 0.050 |
Why?
| | Pelvic Floor | 1 | 2023 | 22 | 0.050 |
Why?
| | Trypsin | 1 | 2023 | 77 | 0.050 |
Why?
| | Snakes | 1 | 2023 | 21 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2023 | 23 | 0.050 |
Why?
| | HeLa Cells | 1 | 2025 | 636 | 0.050 |
Why?
| | Nucleocapsid | 1 | 2023 | 19 | 0.050 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 22 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 289 | 0.050 |
Why?
| | Aminophenols | 1 | 2025 | 156 | 0.050 |
Why?
| | Cyclophilins | 1 | 2023 | 40 | 0.050 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2023 | 173 | 0.050 |
Why?
| | Parturition | 1 | 2023 | 71 | 0.050 |
Why?
| | Chromosomes | 1 | 2023 | 107 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 209 | 0.050 |
Why?
| | Keratinocytes | 1 | 2024 | 249 | 0.050 |
Why?
| | Hormones | 1 | 2023 | 143 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2024 | 216 | 0.050 |
Why?
| | Steroids | 1 | 2023 | 167 | 0.050 |
Why?
| | Serine | 1 | 2023 | 141 | 0.050 |
Why?
| | Proteoglycans | 1 | 2023 | 107 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2025 | 730 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2025 | 465 | 0.050 |
Why?
| | Cardiomegaly | 1 | 2023 | 175 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 73 | 0.050 |
Why?
| | Workflow | 1 | 2023 | 165 | 0.050 |
Why?
| | Oxygen Consumption | 1 | 2025 | 696 | 0.050 |
Why?
| | Exosomes | 1 | 2023 | 103 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2024 | 658 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2024 | 305 | 0.050 |
Why?
| | Viral Proteins | 1 | 2024 | 342 | 0.050 |
Why?
| | ErbB Receptors | 1 | 2025 | 614 | 0.050 |
Why?
| | Sympatry | 1 | 2021 | 16 | 0.050 |
Why?
| | Arginine | 1 | 2023 | 271 | 0.050 |
Why?
| | Complement System Proteins | 1 | 2024 | 327 | 0.040 |
Why?
| | Plasma | 1 | 2023 | 212 | 0.040 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 249 | 0.040 |
Why?
| | Fatty Acids | 1 | 2024 | 443 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 367 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2024 | 534 | 0.040 |
Why?
| | India | 1 | 2021 | 195 | 0.040 |
Why?
| | Phosphorylation | 1 | 2025 | 1759 | 0.040 |
Why?
| | Pregnancy | 2 | 2023 | 6763 | 0.040 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2024 | 405 | 0.040 |
Why?
| | Metabolome | 1 | 2023 | 350 | 0.040 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2020 | 28 | 0.040 |
Why?
| | Myocytes, Cardiac | 1 | 2024 | 526 | 0.040 |
Why?
| | Electron Transport | 1 | 2020 | 115 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2025 | 2486 | 0.040 |
Why?
| | Islands | 1 | 2019 | 4 | 0.040 |
Why?
| | Indonesia | 1 | 2019 | 24 | 0.040 |
Why?
| | Skin | 1 | 2024 | 752 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2019 | 67 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2071 | 0.040 |
Why?
| | Gelatin | 1 | 2019 | 52 | 0.040 |
Why?
| | Pulmonary Artery | 1 | 2024 | 1086 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1457 | 0.040 |
Why?
| | Conserved Sequence | 1 | 2019 | 239 | 0.040 |
Why?
| | Caspase 8 | 1 | 2018 | 48 | 0.040 |
Why?
| | Caspase 9 | 1 | 2018 | 57 | 0.040 |
Why?
| | Fibrinogen | 1 | 2019 | 168 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2018 | 72 | 0.040 |
Why?
| | Guam | 1 | 2017 | 14 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2022 | 425 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2025 | 1317 | 0.040 |
Why?
| | Stem Cells | 1 | 2022 | 594 | 0.030 |
Why?
| | Introduced Species | 1 | 2017 | 39 | 0.030 |
Why?
| | MicroRNAs | 1 | 2024 | 692 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2024 | 1091 | 0.030 |
Why?
| | Disease Progression | 1 | 2025 | 2757 | 0.030 |
Why?
| | Macrophages | 1 | 2025 | 1547 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2022 | 788 | 0.030 |
Why?
| | Ultraviolet Rays | 1 | 2020 | 396 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2023 | 1164 | 0.030 |
Why?
| | Anticoagulants | 1 | 2021 | 664 | 0.030 |
Why?
| | Glutathione | 1 | 2018 | 356 | 0.030 |
Why?
| | Caspase 7 | 1 | 2015 | 22 | 0.030 |
Why?
| | Pakistan | 1 | 2015 | 76 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 810 | 0.030 |
Why?
| | Risk Assessment | 1 | 2023 | 3457 | 0.030 |
Why?
| | Inflammation | 1 | 2024 | 2837 | 0.030 |
Why?
| | Aging | 1 | 2024 | 1864 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2023 | 1724 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1639 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3284 | 0.020 |
Why?
| | Brain | 1 | 2024 | 2668 | 0.020 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 806 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3295 | 0.020 |
Why?
| | Aged | 1 | 2024 | 23961 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 33479 | 0.010 |
Why?
|
|
Saviola's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|